The METTL3-mediated m6A modification level of TIMP2 mRNA may promote podocyte injury, apoptosis in glomeruli, and kidney inflammation through upregulating the Notch3 and Notch 4 signaling pathways (30). The gene discussed is TIMP2; the disease is medical procedure.